These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23592522)

  • 1. p130Cas alters the differentiation potential of mammary luminal progenitors by deregulating c-Kit activity.
    Tornillo G; Elia AR; Castellano I; Spadaro M; Bernabei P; Bisaro B; Camacho-Leal Mdel P; Pincini A; Provero P; Sapino A; Turco E; Defilippi P; Cabodi S
    Stem Cells; 2013 Jul; 31(7):1422-33. PubMed ID: 23592522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
    Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. c-Kit is required for growth and survival of the cells of origin of Brca1-mutation-associated breast cancer.
    Regan JL; Kendrick H; Magnay FA; Vafaizadeh V; Groner B; Smalley MJ
    Oncogene; 2012 Feb; 31(7):869-83. PubMed ID: 21765473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Met signaling regulates growth, repopulating potential and basal cell-fate commitment of mammary luminal progenitors: implications for basal-like breast cancer.
    Gastaldi S; Sassi F; Accornero P; Torti D; Galimi F; Migliardi G; Molyneux G; Perera T; Comoglio PM; Boccaccio C; Smalley MJ; Bertotti A; Trusolino L
    Oncogene; 2013 Mar; 32(11):1428-40. PubMed ID: 22562252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Brca1-deficient mouse mammary glands reveals reciprocal regulation of Brca1 and c-kit.
    Smart CE; Wronski A; French JD; Edwards SL; Asselin-Labat ML; Waddell N; Peters K; Brewster BL; Brooks K; Simpson K; Manning N; Lakhani SR; Grimmond S; Lindeman GJ; Visvader JE; Brown MA
    Oncogene; 2011 Mar; 30(13):1597-607. PubMed ID: 21132007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kit and PDGFR-alpha activities are necessary for Notch4/Int3-induced tumorigenesis.
    Raafat A; Zoltan-Jones A; Strizzi L; Bargo S; Kimura K; Salomon D; Callahan R
    Oncogene; 2007 Feb; 26(5):662-72. PubMed ID: 16878155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p130Cas is an essential transducer element in ErbB2 transformation.
    Cabodi S; Tinnirello A; Bisaro B; Tornillo G; del Pilar Camacho-Leal M; Forni G; Cojoca R; Iezzi M; Amici A; Montani M; Eva A; Di Stefano P; Muthuswamy SK; Tarone G; Turco E; Defilippi P
    FASEB J; 2010 Oct; 24(10):3796-808. PubMed ID: 20505116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of a phosphorylated substrate domain of p130Cas promotes PyMT-induced c-Src-dependent murine breast cancer progression.
    Zhao Y; Kumbrink J; Lin BT; Bouton AH; Yang S; Toselli PA; Kirsch KH
    Carcinogenesis; 2013 Dec; 34(12):2880-90. PubMed ID: 23825155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The caM kinase, Pnck, is spatially and temporally regulated during murine mammary gland development and may identify an epithelial cell subtype involved in breast cancer.
    Gardner HP; Ha SI; Reynolds C; Chodosh LA
    Cancer Res; 2000 Oct; 60(19):5571-7. PubMed ID: 11034105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1.
    Tornillo G; Bisaro B; Camacho-Leal Mdel P; Galiè M; Provero P; Di Stefano P; Turco E; Defilippi P; Cabodi S
    Eur J Cell Biol; 2011; 90(2-3):237-48. PubMed ID: 20961652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis.
    Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS
    Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen receptor beta growth-inhibitory effects are repressed through activation of MAPK and PI3K signalling in mammary epithelial and breast cancer cells.
    Cotrim CZ; Fabris V; Doria ML; Lindberg K; Gustafsson JÅ; Amado F; Lanari C; Helguero LA
    Oncogene; 2013 May; 32(19):2390-402. PubMed ID: 22751110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 controls the plasticity of mammary luminal progenitor cells downstream of Met signaling.
    Chiche A; Di-Cicco A; Sesma-Sanz L; Bresson L; de la Grange P; Glukhova MA; Faraldo MM; Deugnier MA
    Breast Cancer Res; 2019 Jan; 21(1):13. PubMed ID: 30683141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes.
    Amundadottir LT; Leder P
    Oncogene; 1998 Feb; 16(6):737-46. PubMed ID: 9488037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells.
    Hochgräfe F; Zhang L; O'Toole SA; Browne BC; Pinese M; Porta Cubas A; Lehrbach GM; Croucher DR; Rickwood D; Boulghourjian A; Shearer R; Nair R; Swarbrick A; Faratian D; Mullen P; Harrison DJ; Biankin AV; Sutherland RL; Raftery MJ; Daly RJ
    Cancer Res; 2010 Nov; 70(22):9391-401. PubMed ID: 20861192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deregulated ephrin-B2 signaling in mammary epithelial cells alters the stem cell compartment and interferes with the epithelial differentiation pathway.
    Kaenel P; Antonijevic M; Richter S; Küchler S; Sutter N; Wotzkow C; Strange R; Andres AC
    Int J Oncol; 2012 Feb; 40(2):357-69. PubMed ID: 22020958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annexin A8 identifies a subpopulation of transiently quiescent c-kit positive luminal progenitor cells of the ductal mammary epithelium.
    Iglesias JM; Cairney CJ; Ferrier RK; McDonald L; Soady K; Kendrick H; Pringle MA; Morgan RO; Martin F; Smalley MJ; Blyth K; Stein T
    PLoS One; 2015; 10(3):e0119718. PubMed ID: 25803307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p130Cas over-expression impairs mammary branching morphogenesis in response to estrogen and EGF.
    Camacho Leal Mdel P; Pincini A; Tornillo G; Fiorito E; Bisaro B; Di Luca E; Turco E; Defilippi P; Cabodi S
    PLoS One; 2012; 7(12):e49817. PubMed ID: 23239970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer stemness in Wnt-driven mammary tumorigenesis.
    Monteiro J; Gaspar C; Richer W; Franken PF; Sacchetti A; Joosten R; Idali A; Brandao J; Decraene C; Fodde R
    Carcinogenesis; 2014 Jan; 35(1):2-13. PubMed ID: 23955540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive activation of RANK disrupts mammary cell fate leading to tumorigenesis.
    Pellegrini P; Cordero A; Gallego MI; Dougall WC; Muñoz P; Pujana MA; Gonzalez-Suarez E
    Stem Cells; 2013 Sep; 31(9):1954-65. PubMed ID: 23766243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.